drugset

drugset / Trial / NCT00310713

Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine

NCT00310713 ↗

Phase 4 Completed 33 enrolled Novartis Vaccines

Non-randomizedSingle-groupOpen-labelPrevention

Summary

Persistence of antibodies and kinetics of B cell response in healthy children after vaccination with MCC vaccine

Timeline

Start: 2006-04
Primary completion: 2006-08
Completion: 2006-08

Publications

Background Blanchard Rohner G, Snape MD, Kelly DF, John T, Morant A, Yu LM, Borkowski A, Ceddia F, Borrow R, Siegrist CA, Pollard AJ. The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response. J Immunol. 2008 Feb 15;180(4):2165-73. doi: 10.4049/jimmunol.180.4.2165.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Menjugate	Vaccine	—	—

Indications